Pentoxifylline Extended-Release Tablets

This is a preview of
USP-NF/PF content.

Subscriber?
Access here! Not a subscriber?
Learn more!

» Pentoxifylline Extended-Release Tablets contain not less than 95.0 percent and not more than 105.0 percent of the labeled amount of pentoxifylline (C₁₃H₁₈N₄O₃).

USP REFERENCE STANDARDS FOR PURCHASE

USP Pentoxifylline RS

This is a preview of
USP-NF/PF content.

Subscriber?
Access here!Not a subscriber?
Learn more!